ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,086.49
0.61%
US Tech 100
20,896.00
1.07%
다우존스 지수
45,014.04
0.69%
Bitcoin
101,007.06
2.28%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Rtw Biotech Opportunities Ltd (RTW)

  7. Rtw Biotech Opportunities Ltd (RTW) 뉴스

RTW

Rtw Biotech Opportunities (RTW)

Rtw Biotech Opportunities Ltd
일자:
정렬 기준:
 검색 관련기사 보기:LSE:RTW
일자시간출처헤드라인심볼기업
2024/11/1519:02Alliance NewsAlliance NewsIN BRIEF: RTW Biotech notes drug approval in China for investee CorxelLSE:RTWRtw Biotech Opportunities Ltd
2024/11/1519:02Alliance NewsAlliance NewsIN BRIEF: RTW Biotech notes drug approval in China for investee CorxelLSE:RTWRtw Biotech Opportunities Ltd
2024/11/1516:00RNS Regulatory NewsRTW Biotech Opportunities Ltd CORXEL Announces Acceptance of NDA for AficamtenLSE:RTWRtw Biotech Opportunities Ltd
2024/11/1416:00RNS Regulatory NewsRTW Biotech Opportunities Ltd Monthly Valuation Update and FactsheetLSE:RTWRtw Biotech Opportunities Ltd
2024/11/0415:50Alliance NewsAlliance NewsIN BRIEF: RTW Biotech invests in inflammation treatment firm EvommuneLSE:RTWRtw Biotech Opportunities Ltd
2024/11/0415:50Alliance NewsAlliance NewsIN BRIEF: RTW Biotech invests in inflammation treatment firm EvommuneLSE:RTWRtw Biotech Opportunities Ltd
2024/11/0123:00RNS Regulatory NewsRTW Biotech Opportunities Ltd New Investment in Series C Round of Evommune, Inc.LSE:RTWRtw Biotech Opportunities Ltd
2024/11/0116:00RNS Regulatory NewsRTW Biotech Opportunities Ltd RTW Biotech Opportunities’ 5th AnniversaryLSE:RTWRtw Biotech Opportunities Ltd
2024/10/1502:12RNS Regulatory NewsRTW Biotech Opportunities Ltd Monthly Valuation Update and Factsheet ReplacementLSE:RTWRtw Biotech Opportunities Ltd
2024/10/1415:00RNS Regulatory NewsRTW Biotech Opportunities Ltd Monthly Valuation Update and FactsheetLSE:RTWRtw Biotech Opportunities Ltd
2024/10/0320:59Alliance NewsAlliance NewsRTW Biotech Opportunities announces launch of Kailera TherapeuticsLSE:RTWRtw Biotech Opportunities Ltd
2024/10/0320:59Alliance NewsAlliance NewsRTW Biotech Opportunities announces launch of Kailera TherapeuticsLSE:RTWRtw Biotech Opportunities Ltd
2024/10/0315:00RNS Regulatory NewsRTW Biotech Opportunities Ltd Launch of Obesity Company Kailera TherapeuticsLSE:RTWRtw Biotech Opportunities Ltd
2024/10/0219:05Alliance NewsAlliance NewsIN BRIEF: RTW Biotech invests in cancer treatment firm Aktis OncologyLSE:RTWRtw Biotech Opportunities Ltd
2024/10/0219:05Alliance NewsAlliance NewsIN BRIEF: RTW Biotech invests in cancer treatment firm Aktis OncologyLSE:RTWRtw Biotech Opportunities Ltd
2024/10/0215:00RNS Regulatory NewsRTW Biotech Opportunities Ltd New Investment in Aktis OncologyLSE:RTWRtw Biotech Opportunities Ltd
2024/09/2720:19Alliance NewsAlliance NewsRTW Biotech notes BioAge Labs' USD198 million initial public offeringLSE:RTWRtw Biotech Opportunities Ltd
2024/09/2720:19Alliance NewsAlliance NewsRTW Biotech notes BioAge Labs' USD198 million initial public offeringLSE:RTWRtw Biotech Opportunities Ltd
2024/09/2715:00RNS Regulatory NewsRTW Biotech Opportunities Ltd BioAge Labs completes $198 million IPOLSE:RTWRtw Biotech Opportunities Ltd
2024/09/2615:00RNS Regulatory NewsRTW Biotech Opportunities Ltd GBP quote for the share class to ceaseLSE:RTWRtw Biotech Opportunities Ltd
2024/09/1615:00RNS Regulatory NewsRTW Biotech Opportunities Ltd Monthly Valuation Update and FactsheetLSE:RTWRtw Biotech Opportunities Ltd
2024/09/1318:48Alliance NewsAlliance NewsRTW Biotech half-year net asset value rises amid "challenging markets"LSE:RTWRtw Biotech Opportunities Ltd
2024/09/1318:48Alliance NewsAlliance NewsRTW Biotech half-year net asset value rises amid "challenging markets"LSE:RTWRtw Biotech Opportunities Ltd
2024/09/1315:00RNS Regulatory NewsRTW Biotech Opportunities Ltd Half-year ReportLSE:RTWRtw Biotech Opportunities Ltd
2024/08/1415:01RNS Regulatory NewsRTW Biotech Opportunities Ltd Closed Period NotificationLSE:RTWRtw Biotech Opportunities Ltd
2024/08/1415:00RNS Regulatory NewsRTW Biotech Opportunities Ltd Monthly Valuation Update and FactsheetLSE:RTWRtw Biotech Opportunities Ltd
2024/08/0700:51Alliance NewsAlliance NewsEARNINGS AND TRADING: Epwin in line; Airea's "unforeseen slowdown"LSE:RTWRtw Biotech Opportunities Ltd
2024/08/0700:51Alliance NewsAlliance NewsEARNINGS AND TRADING: Epwin in line; Airea's "unforeseen slowdown"LSE:RTWRtw Biotech Opportunities Ltd
2024/08/0615:00RNS Regulatory NewsRTW Biotech Opportunities Ltd New Investment in Jade Biosciences, IncLSE:RTWRtw Biotech Opportunities Ltd
2024/07/2220:00RNS Regulatory NewsRTW Biotech Opportunities Ltd Artiva Biotherapeutics prices IPO at $167 millionLSE:RTWRtw Biotech Opportunities Ltd
 검색 관련기사 보기:LSE:RTW

최근 히스토리

AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
USOTC
ADDYY
Adidas (QX)
NASDAQ
NVDA
NVIDIA
FX
USDJPY
US Dollar vs Yen
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MRK
Merck
NASDAQ
TSLA
Tesla
CCOM
US100
US Tech 100
USOTC
BASFY
BASF (QX)
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
COIN
XRPUSD
Ripple
NYSE
XOM
Exxon Mobil
FX
USDGBP
US Dollar vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유